Xiang Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiang Li has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Jingang An
Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, PR China
1 shared publication - KuanKuan Jia
Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China
1 shared publication Lihang Shen
Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China
1 shared publication- Shuo Chen
Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing 100081, China
1 shared publication
Latest Publications
- Open Access
- 3 June 2026
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 9 (8) , e202603772
A novel SLC2A10 gain-of-function variant links glycolytic macrophage polarization to chronic nonbacterial osteomyelitis
Chronic nonbacterial osteomyelitis is a rare autoinflammatory bone disorder with unclear etiology. In a Chinese family, whole-exome sequencing identified a heterozygous missense variant in SLC2A10 that cosegregated with disease. Structural modeling suggested that the substitution disrupts hydrogen bond within the transmembrane domain, potentially altering glucose transport activity. In vitro, the expression of the p.Asp292Glu variant in macrophages enhanced glucose uptake, increased glycolytic activity, and promoted pro-inflammatory polarization, accompanied by increased production of inflammatory mediators. The variant also accelerated osteoclast differentiation and suppressed osteoblast-mediated mineralization, indicating a disruption of bone homeostasis. Zebrafish expressing the p.Asp292Glu variant exhibited enhanced inflammatory responses, increased reactive oxygen species accumulation, elevated macrophage infiltration in the mandibular region, and impaired bone mineralization. Transcriptomic analysis confirmed activation of glycolytic and inflammatory signaling pathways, as well as enrichment of osteoclast differentiation networks. These findings demonstrate that the SLC2A10 variant exerts a gain-of-function effect driving glycolysis-dependent macrophage polarization and osteoclastogenesis, leading to chronic inflammatory bone destruction. This study broadens the genetic understanding of chronic nonbacterial osteomyelitis and suggests a potential therapeutic target.
- 3 June 2026
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 9 (8) , e202603772
Open AccessA novel SLC2A10 gain-of-function variant links glycolytic macrophage polarization to chronic nonbacterial osteomyelitis
Chronic nonbacterial osteomyelitis is a rare autoinflammatory bone disorder with unclear etiology. In a Chinese family, whole-exome sequencing identified a heterozygous missense variant in SLC2A10 that cosegregated with disease. Structural modeling suggested that the substitution disrupts hydrogen bond within the transmembrane domain, potentially altering glucose transport activity. In vitro, the expression of the p.Asp292Glu variant in macrophages enhanced glucose uptake, increased glycolytic activity, and promoted pro-inflammatory polarization, accompanied by increased production of inflammatory mediators. The variant also accelerated osteoclast differentiation and suppressed osteoblast-mediated mineralization, indicating a disruption of bone homeostasis. Zebrafish expressing the p.Asp292Glu variant exhibited enhanced inflammatory responses, increased reactive oxygen species accumulation, elevated macrophage infiltration in the mandibular region, and impaired bone mineralization. Transcriptomic analysis confirmed activation of glycolytic and inflammatory signaling pathways, as well as enrichment of osteoclast differentiation networks. These findings demonstrate that the SLC2A10 variant exerts a gain-of-function effect driving glycolysis-dependent macrophage polarization and osteoclastogenesis, leading to chronic inflammatory bone destruction. This study broadens the genetic understanding of chronic nonbacterial osteomyelitis and suggests a potential therapeutic target.